Literature DB >> 15362574

Phenotype-genotype correlation in two patients with 12q proximal deletion.

Noriko Miyake1, Hidefumi Tonoki, Marta Gallego, Naoki Harada, Osamu Shimokawa, Koh-ichiro Yoshiura, Tohru Ohta, Tatsuya Kishino, Norio Niikawa, Naomichi Matsumoto.   

Abstract

Proximal 12q deletion is a very rare chromosomal abnormality. Only five cases have been reported. Among the five, an Argentinian patient (Case 1) with del(12)(q11q13) and a Japanese patient (Case 2) with del(12)(q12q13.12) were analyzed because they shared several clinical features: growth and psychomotor developmental delay; strabismus; broad and short nose with anteverted nostrils; high, arched palate; large, lowset ears; widely set nipples; short fingers and clinodactyly of fifth fingers; and abnormality of the second and third toes. To clarify the correlation between the deleted genes and their phenotypes, we delimited their deleted regions by fluorescence in situ hybridization (FISH). The overlapped region in the deletions spanned 6.2 Mb where at least 15 genes were predicted to localize on the current human genome database. Among them, YAF2 and AMIGO2 were the most plausible candidates to affect growth and psychomotor retardation, respectively, in both cases. Regarding unique symptoms in each case, congenital fibrosis of the extraocular muscles found only in Case 1 may be caused by KIF21A deletion and hearing loss and cleft palate in Case 2 by COL2A1 defect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362574     DOI: 10.1007/s10038-004-0144-5

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

1.  Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1).

Authors:  Koki Yamada; Caroline Andrews; Wai-Man Chan; Craig A McKeown; Adriano Magli; Teresa de Berardinis; Anat Loewenstein; Moshe Lazar; Michael O'Keefe; Robert Letson; Arnold London; Mark Ruttum; Naomichi Matsumoto; Nakamichi Saito; Lisa Morris; Monte Del Monte; Roger H Johnson; Eiichiro Uyama; Willem A Houtman; Berendina de Vries; Thomas J Carlow; Blaine L Hart; Nicolas Krawiecki; John Shoffner; Marlene C Vogel; James Katowitz; Scott M Goldstein; Alex V Levin; Emin C Sener; Banu T Ozturk; A Nurten Akarsu; Michael C Brodsky; Frank Hanisch; Robert P Cruse; Alina A Zubcov; Richard M Robb; Peter Roggenkäemper; Irene Gottlob; Lionel Kowal; Ravi Battu; Elias I Traboulsi; Piergiorgio Franceschini; Anna Newlin; Joseph L Demer; Elizabeth C Engle
Journal:  Nat Genet       Date:  2003-11-02       Impact factor: 38.330

2.  Yeast two-hybrid cloning of a novel zinc finger protein that interacts with the multifunctional transcription factor YY1.

Authors:  J L Kalenik; D Chen; M E Bradley; S J Chen; T C Lee
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

3.  Deletion (12)(q15q21.2).

Authors:  M S Watson; L McAllister-Barton; M J Mahoney; W R Breg
Journal:  J Med Genet       Date:  1989-05       Impact factor: 6.318

Review 4.  Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels.

Authors:  H Kuivaniemi; G Tromp; D J Prockop
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

5.  Patient with del(12)(q12q13.12) manifesting abnormalities compatible with Noonan syndrome.

Authors:  H Tonoki; S Saitoh; K Kobayashi
Journal:  Am J Med Genet       Date:  1998-02-03

6.  Multiple malformation syndrome including cleft lip and palate and cardiac abnormalities due to an interstitial deletion of chromosome 12q.

Authors:  P Meinecke; R Meinecke
Journal:  J Med Genet       Date:  1987-03       Impact factor: 6.318

7.  Small deletions in the type II collagen triple helix produce kniest dysplasia.

Authors:  D J Wilkin; A S Artz; S South; R S Lachman; D L Rimoin; W R Wilcox; V A McKusick; C A Stratakis; C A Francomano; D H Cohn
Journal:  Am J Med Genet       Date:  1999-07-16

8.  De novo deletion 12q: report of a patient with 12q24.31q24.33 deletion.

Authors:  P Sathya; D J Tomkins; V Freeman; B Paes; M J Nowaczyk
Journal:  Am J Med Genet       Date:  1999-05-21

9.  AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats.

Authors:  Juha Kuja-Panula; Marjaana Kiiltomäki; Takashi Yamashiro; Ari Rouhiainen; Heikki Rauvala
Journal:  J Cell Biol       Date:  2003-03-10       Impact factor: 10.539

  9 in total
  3 in total

1.  The expanding spectrum of COL2A1 gene variants IN 136 patients with a skeletal dysplasia phenotype.

Authors:  Mouna Barat-Houari; Bruno Dumont; Aurélie Fabre; Frédéric Tm Them; Yves Alembik; Jean-Luc Alessandri; Jeanne Amiel; Séverine Audebert; Clarisse Baumann-Morel; Patricia Blanchet; Eric Bieth; Marie Brechard; Tiffany Busa; Patrick Calvas; Yline Capri; François Cartault; Nicolas Chassaing; Vidrica Ciorca; Christine Coubes; Albert David; Anne-Lise Delezoide; Delphine Dupin-Deguine; Salima El Chehadeh; Laurence Faivre; Fabienne Giuliano; Alice Goldenberg; Bertrand Isidor; Marie-Line Jacquemont; Sophie Julia; Josseline Kaplan; Didier Lacombe; Marine Lebrun; Sandrine Marlin; Dominique Martin-Coignard; Jelena Martinovic; Alice Masurel; Judith Melki; Monique Mozelle-Nivoix; Karine Nguyen; Sylvie Odent; Nicole Philip; Lucile Pinson; Ghislaine Plessis; Chloé Quélin; Elise Shaeffer; Sabine Sigaudy; Christel Thauvin; Marianne Till; Renaud Touraine; Jacqueline Vigneron; Geneviève Baujat; Valérie Cormier-Daire; Martine Le Merrer; David Geneviève; Isabelle Touitou
Journal:  Eur J Hum Genet       Date:  2015-12-02       Impact factor: 4.246

2.  Deletion at 12q12 increases the risk of developmental delay and intellectual disability.

Authors:  Ying Weng; Xiaoping Luo; Ling Hou
Journal:  Ann Hum Genet       Date:  2018-08-29       Impact factor: 1.670

3.  Comparative Genomic Mapping Implicates LRRK2 for Intellectual Disability and Autism at 12q12, and HDHD1, as Well as PNPLA4, for X-Linked Intellectual Disability at Xp22.31.

Authors:  Jonathan D J Labonne; Terri M Driessen; Marvin E Harris; Il-Keun Kong; Soumia Brakta; John Theisen; Modibo Sangare; Lawrence C Layman; Cheol-Hee Kim; Janghoo Lim; Hyung-Goo Kim
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.